Upper Tract Urothelial Cancer

Questions discussed in this category

Do you plan to extrapolate from the NIAGARA trial regarding peri-operative durvalumab/cis/gem to treat upper tract urothelial carcinoma?

5 Answers available

Papers discussed in this category

Lancet, 2020 Mar 05

Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial.

J Clin Oncol, 2023 Mar 10

Multicenter Phase II Clinical Trial of Gemcitabine and Cisplatin as Neoadjuvant Chemotherapy for Patients With High-Grade Upper Tract Urothelial Carcinoma.

The New England journal of medicine, 2024 Sep 15

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.

The New England journal of medicine, 2024 Mar 07

Enfortumab Vedotin and Pembrolizumab in Untreated Advanced Urothelial Cancer.

N Engl J Med,

Adjuvant Nivolumab versus Placebo in Muscle-Invasive Urothelial Carcinoma.

Related Topics